LL-37 vs ARA-290 Research Comparison

Home › Research Library › LL-37 vs ARA-290 Research Comparison

What Is the Difference Between LL-37 and ARA-290?

Although LL-37 and ARA-290 are frequently discussed within tissue repair research, they represent different peptide families and are studied for distinct biological functions.

LL-37 is a synthetic form of the naturally occurring human cathelicidin antimicrobial peptide. Researchers investigate its role in innate immunity, antimicrobial defense, inflammatory signaling, tissue remodeling, and wound-healing models.

ARA-290 is a synthetic peptide derived from erythropoietin (EPO). Laboratory studies examine its interaction with innate repair receptor (IRR) signaling, tissue-protective pathways, cellular stress responses, and inflammatory communication without stimulating red blood cell production.

Biological Origin

LL-37

LL-37 is produced naturally from the precursor protein hCAP18 and functions as the body's only known cathelicidin antimicrobial peptide. It is expressed by immune cells and epithelial tissues as part of the innate immune response.

ARA-290

ARA-290 is a synthetic peptide modeled after a small region of erythropoietin. Unlike full-length erythropoietin, ARA-290 is studied for tissue-protective signaling rather than hematopoietic activity.

Research Focus Comparison

LL-37 Research

Current laboratory investigations involving LL-37 focus on antimicrobial activity, innate immune communication, inflammatory signaling, extracellular matrix remodeling, tissue organization, and wound-healing models. Researchers continue exploring how LL-37 coordinates early immune responses and tissue-level cellular communication.

→ View LL-37 Research Overview

ARA-290 Research

Research involving ARA-290 examines tissue-protective signaling pathways, innate repair receptor activation, inflammatory communication, cellular stress responses, and tissue preservation models. Scientists continue studying how ARA-290 interacts with biological signaling pathways associated with cellular resilience and repair.

→ View ARA-290 Research Overview

Shared Areas of Research Interest

Although LL-37 and ARA-290 originate from different peptide families, both are investigated in laboratory environments involving:

• Tissue repair research
• Inflammatory signaling pathways
• Cellular communication
• Immune system research
• Wound-healing models
• Tissue remodeling

How Researchers Compare These Peptides

Researchers compare LL-37 and ARA-290 because both are studied within tissue biology, yet they participate in different signaling systems. LL-37 research emphasizes antimicrobial activity and innate immune communication, while ARA-290 research focuses on tissue-protective signaling, innate repair mechanisms, and cellular stress responses.

Together, these peptides provide complementary perspectives on tissue biology and immune-related laboratory research.

Related Research Pages

• LL-37 Research Overview
• ARA-290 Research Overview
• KPV Research Overview
• BPC-157 Research Overview
• TB-500 Research Overview
• GHK-Cu Research Overview
• LL-37 vs KPV Research Comparison
• LL-37 vs BPC-157 Research Comparison

Explore More Tissue Repair Research

• Peptides Studied for Tissue Repair Research
• Research Peptide Directory
• Research Comparisons
• Research Library

Quick Summary

LL-37 and ARA-290 are both studied in laboratory models involving tissue biology and inflammatory signaling, but they are investigated through different biological mechanisms. LL-37 research focuses on innate immune defense, antimicrobial activity, tissue remodeling, and wound-healing pathways, while ARA-290 research emphasizes tissue-protective signaling, innate repair receptor activity, and cellular stress response pathways.

Research Use Notice

All information provided by Riptidez is intended strictly for educational and laboratory research purposes. LL-37 and ARA-290 are not approved for human consumption, veterinary use, or therapeutic application.